Advertisement
When should a housing society in Mumbai start considering re...
From GST on JDAs to SEBI’s REIT reclassification and the S...
Stay ahead in the world of real estate with our daily podcas...
Stay ahead in the world of real estate with our daily podcas...
British Land has agreed to acquire Life Science REIT in a deal valuing the trust at about GBP 150 million, or USD 207.1 million. The transaction marks British Land's entry into the life sciences real estate segment, expanding beyond its traditional focus on retail parks and mixed-use developments. Life Science REIT owns assets catering to research and laboratory occupiers, a sector that has seen sustained demand in the UK. The deal reflects British Land's strategy to diversify into property segments with long-term growth potential.
British Land, the UK's largest direct owner and operator of retail parks, has agreed to acquire Life Science REIT in a transaction that values the specialist property trust at around GBP 150 million, equivalent to USD 207.1 million. The buyer confirmed that the deal will bring the life sciences-focused real estate portfolio under its ownership, marking a strategic expansion beyond its core retail and mixed-use assets. Advertisement
The acquisition reflects British Land's continued effort to diversify its property exposure at a time when demand for laboratory and research space remains resilient across key UK cities. Life Science REIT owns and manages assets primarily focused on facilities used by biotechnology, pharmaceutical, and research-led occupiers, a segment that has gained investor attention over the past few years due to long-term structural demand.
British Land has historically concentrated on retail parks, offices, and major mixed-use developments in London and other urban centres. In recent years, the group has signalled interest in sectors supported by stable occupier demand and longer lease profiles, including urban logistics and alternative real estate segments. The move to acquire Life Science REIT aligns with this broader shift in capital allocation strategy.
Life Science REIT was established to capitalise on the growing need for purpose-built laboratory infrastructure in the UK, where supply has struggled to keep pace with demand from research-intensive industries. The trust's assets are typically located near academic institutions and established science clusters, which has supported occupancy and rental growth despite wider volatility in commercial property markets.
The transaction values Life Science REIT at approximately USD 207.1 million, based on prevailing exchange rates where USD 1 is equivalent to around GBP 0.7244. The acquisition is expected to consolidate British Land's position in a segment that benefits from strong tenant covenants and long-term growth drivers linked to healthcare, innovation, and research funding.
Source Reuters
5th Jun, 2025
25th May, 2023
11th May, 2023
27th Apr, 2023
Advertisement
Facebook
Whatsapp
